Comparison of two transdermal nitroglycerin systems. 1986

C Godoy, and B R Greenspahn, and M J Kushner, and R E Lahti, and R A Levy, and P Reese, and G M Reynolds, and S C Rice

In a study conducted by office-based cardiologists at eight sites, 115 patients using transdermal nitroglycerin for treatment of angina pectoris participated in a four-week comparison of two transdermal nitroglycerin patches: Transderm-Nitro (TDN) and Nitro-Dur II (ND II). Patients wore two patches, one of each brand, each with half their normal prescribed daily dose of 10 mg (release rate per 24 hours) to compare patch adherence properties, patient preference, and local side effects. More ND II than TDN patches fell off (5% versus 0.1%), and fewer TDN than ND II patches became loose (1.7% versus 8.4%); 98.2% of the TDN and 86.7% of the ND II patches adhered totally. Significantly more patients expressed a preference for TDN over ND II in four of eight assessment variables, including the choice of their next prescription. The frequency of problems at the site of patch application was similar with both patches.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005996 Nitroglycerin A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. Glyceryl Trinitrate,Anginine,Dynamite,Gilustenon,Nitrangin,Nitro-Bid,Nitro-Dur,Nitrocard,Nitroderm,Nitroderm TTS,Nitroglyn,Nitrol,Nitrolan,Nitrong,Nitrospan,Nitrostat,Perlinganit,Susadrin,Sustac,Sustak,Sustonit,Transderm Nitro,Tridil,Trinitrin,Trinitrolong,Nitro Bid,Nitro Dur,NitroBid,NitroDur,Trinitrate, Glyceryl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000268 Adhesiveness A property of the surface of an object that makes it stick to another surface. Adhesivenesses
D000279 Administration, Cutaneous The application of suitable drug dosage forms to the skin for either local or systemic effects. Cutaneous Drug Administration,Dermal Drug Administration,Drug Administration, Dermal,Percutaneous Administration,Skin Drug Administration,Transcutaneous Administration,Transdermal Administration,Administration, Dermal,Administration, Transcutaneous,Administration, Transdermal,Cutaneous Administration,Cutaneous Administration, Drug,Dermal Administration,Drug Administration, Cutaneous,Skin Administration, Drug,Administration, Cutaneous Drug,Administration, Dermal Drug,Administration, Percutaneous,Administrations, Cutaneous,Administrations, Cutaneous Drug,Administrations, Dermal,Administrations, Dermal Drug,Administrations, Percutaneous,Administrations, Transcutaneous,Administrations, Transdermal,Cutaneous Administrations,Cutaneous Administrations, Drug,Cutaneous Drug Administrations,Dermal Administrations,Dermal Drug Administrations,Drug Administrations, Cutaneous,Drug Administrations, Dermal,Drug Skin Administrations,Percutaneous Administrations,Skin Administrations, Drug,Skin Drug Administrations,Transcutaneous Administrations,Transdermal Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

C Godoy, and B R Greenspahn, and M J Kushner, and R E Lahti, and R A Levy, and P Reese, and G M Reynolds, and S C Rice
January 1991, Clinical therapeutics,
C Godoy, and B R Greenspahn, and M J Kushner, and R E Lahti, and R A Levy, and P Reese, and G M Reynolds, and S C Rice
January 1985, Clinical therapeutics,
C Godoy, and B R Greenspahn, and M J Kushner, and R E Lahti, and R A Levy, and P Reese, and G M Reynolds, and S C Rice
January 1992, Clinical therapeutics,
C Godoy, and B R Greenspahn, and M J Kushner, and R E Lahti, and R A Levy, and P Reese, and G M Reynolds, and S C Rice
January 1985, Clinical therapeutics,
C Godoy, and B R Greenspahn, and M J Kushner, and R E Lahti, and R A Levy, and P Reese, and G M Reynolds, and S C Rice
April 1982, The Medical letter on drugs and therapeutics,
C Godoy, and B R Greenspahn, and M J Kushner, and R E Lahti, and R A Levy, and P Reese, and G M Reynolds, and S C Rice
July 1982, American journal of hospital pharmacy,
C Godoy, and B R Greenspahn, and M J Kushner, and R E Lahti, and R A Levy, and P Reese, and G M Reynolds, and S C Rice
August 1996, American journal of therapeutics,
C Godoy, and B R Greenspahn, and M J Kushner, and R E Lahti, and R A Levy, and P Reese, and G M Reynolds, and S C Rice
August 1987, Clinical pharmacy,
C Godoy, and B R Greenspahn, and M J Kushner, and R E Lahti, and R A Levy, and P Reese, and G M Reynolds, and S C Rice
February 1989, Journal of the American College of Cardiology,
C Godoy, and B R Greenspahn, and M J Kushner, and R E Lahti, and R A Levy, and P Reese, and G M Reynolds, and S C Rice
December 1986, American heart journal,
Copied contents to your clipboard!